Skip to main content
Clinical Trials/TCTR20240709003
TCTR20240709003RecruitingNot Applicable

Effects of testosterone treatment on endothelial function among transgender male

Ratchadapisek Research Funds0 sites10 target enrollmentStarted: July 9, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20 Years to 40 Years (—)
Sex
Female

Inclusion Criteria

  • Women age 20-40 years who desire to be transgender male
  • have not received GAHT and performed gender reassignment surgery

Exclusion Criteria

  • Having history of clinical atherosclerosis, metabolic disease, hypertension, gynecologic disease
  • Using cardiovascular medication or medication that would affect
  • vasoconstriction or vasodilation or testosterone metabolism

Investigators

Sponsor
Ratchadapisek Research Funds

Similar Trials